Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry

Masahiro Ayano; Naoyasu Ueda; Koji Mishima; Shun Ichiro Ota; Kazuo Kushimoto; Atsushi Tanaka; Goro Doi; Tsuyoshi Nakayama; Makiko Maekawa; Tomomi Tsuru; Mitsuteru Akahoshi; Koichi Akashi; Takahiko Horiuchi; Hiroaki Niiro

doi:10.1016/j.jbspin.2025.105882

Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry

Masahiro Ayano, Naoyasu Ueda, Koji Mishima, Shun Ichiro Ota, Kazuo Kushimoto, Atsushi Tanaka, Goro Doi, Tsuyoshi Nakayama, Makiko Maekawa, Tomomi Tsuru, Mitsuteru Akahoshi, Koichi Akashi, Takahiko Horiuchi, Hiroaki Niiro

Medical Education

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	105882
Journal	Joint Bone Spine
Volume	92
Issue number	4
DOIs	https://doi.org/10.1016/j.jbspin.2025.105882
Publication status	Published - Jul 2025

All Science Journal Classification (ASJC) codes

Rheumatology

Access to Document

10.1016/j.jbspin.2025.105882

Cite this

Ayano, M., Ueda, N., Mishima, K., Ota, S. I., Kushimoto, K., Tanaka, A., Doi, G., Nakayama, T., Maekawa, M., Tsuru, T., Akahoshi, M., Akashi, K., Horiuchi, T., & Niiro, H. (2025). Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry. Joint Bone Spine, 92(4), Article 105882. https://doi.org/10.1016/j.jbspin.2025.105882

Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry. / Ayano, Masahiro; Ueda, Naoyasu; Mishima, Koji et al.
In: Joint Bone Spine, Vol. 92, No. 4, 105882, 07.2025.

Research output: Contribution to journal › Letter › peer-review

Ayano, M, Ueda, N, Mishima, K, Ota, SI, Kushimoto, K, Tanaka, A, Doi, G, Nakayama, T, Maekawa, M, Tsuru, T, Akahoshi, M, Akashi, K, Horiuchi, T & Niiro, H 2025, 'Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry', Joint Bone Spine, vol. 92, no. 4, 105882. https://doi.org/10.1016/j.jbspin.2025.105882

Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A et al. Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry. Joint Bone Spine. 2025 Jul;92(4):105882. doi: 10.1016/j.jbspin.2025.105882

@article{9f7432b8f1034414b5bf91f5cbd5473c,

title = "Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-na{\"i}ve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry",

author = "Masahiro Ayano and Naoyasu Ueda and Koji Mishima and Ota, {Shun Ichiro} and Kazuo Kushimoto and Atsushi Tanaka and Goro Doi and Tsuyoshi Nakayama and Makiko Maekawa and Tomomi Tsuru and Mitsuteru Akahoshi and Koichi Akashi and Takahiko Horiuchi and Hiroaki Niiro",

year = "2025",

month = jul,

doi = "10.1016/j.jbspin.2025.105882",

language = "English",

volume = "92",

journal = "Joint Bone Spine",

issn = "1297-319X",

publisher = "Elsevier Masson s.r.l.",

number = "4",

}

TY - JOUR

T1 - Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus

T2 - Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry

AU - Ayano, Masahiro

AU - Ueda, Naoyasu

AU - Mishima, Koji

AU - Ota, Shun Ichiro

AU - Kushimoto, Kazuo

AU - Tanaka, Atsushi

AU - Doi, Goro

AU - Nakayama, Tsuyoshi

AU - Maekawa, Makiko

AU - Tsuru, Tomomi

AU - Akahoshi, Mitsuteru

AU - Akashi, Koichi

AU - Horiuchi, Takahiko

AU - Niiro, Hiroaki

PY - 2025/7

Y1 - 2025/7

UR - http://www.scopus.com/inward/record.url?scp=105000678873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=105000678873&partnerID=8YFLogxK

U2 - 10.1016/j.jbspin.2025.105882

DO - 10.1016/j.jbspin.2025.105882

M3 - Letter

C2 - 40090613

AN - SCOPUS:105000678873

SN - 1297-319X

VL - 92

JO - Joint Bone Spine

JF - Joint Bone Spine

IS - 4

M1 - 105882

ER -

Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this